Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Amarantus Bioscience Holdings, Inc. | Financial_Report.xls |
| EX-23.1 - EXHIBIT 23.1 - Amarantus Bioscience Holdings, Inc. | v401261_ex23-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Amarantus Bioscience Holdings, Inc. | v401261_ex21-1.htm |
| EX-32.1 - EXHIBIT 32.1 - Amarantus Bioscience Holdings, Inc. | v401261_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - Amarantus Bioscience Holdings, Inc. | v401261_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Amarantus Bioscience Holdings, Inc. | v401261_ex31-2.htm |
| EX-10.53 - EXHIBIT 10.53 - Amarantus Bioscience Holdings, Inc. | v401261_ex10-53.htm |
| EX-10.52 - EXHIBIT 10.52 - Amarantus Bioscience Holdings, Inc. | v401261_ex10-52.htm |
| EX-10.54 - EXHIBIT 10.54 - Amarantus Bioscience Holdings, Inc. | v401261_ex10-54.htm |
| 10-K - FORM 10-K - Amarantus Bioscience Holdings, Inc. | v401261_10k.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Robert Farrell, the Chief Financial Officer of Amarantus BioScience Holdings, Inc. (the “Company”), hereby certify, that, to my knowledge:
1. The Annual Report on Form 10-K for the year ended December 31, 2014 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: April 3, 2015 | /s/ Robert Farrell |
| Robert Farrell | |
|
Chief Financial Officer (Principal Financial Officer) |